| Patricia Anne Givens, | |
|
1327 Kalakaket Street, Fairbanks, AK 99709 | |
| (907) 452-4517 | |
| (907) 452-4263 |
| Full Name | Patricia Anne Givens |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1327 Kalakaket Street, Fairbanks, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922371590 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 429 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Anne Givens, 1327 Kalakaket St, Fairbanks, AK 99709-4917 Ph: (907) 452-4517 | Patricia Anne Givens, 1327 Kalakaket Street, Fairbanks, AK 99709 Ph: (907) 452-4517 |
News Archive
"We don't need to start fresh to create patient-centered medical homes. We just need to look to community-based models of care that are effective but often go unrecognized," according to a Boston Globe opinion piece by Heidi Behforouz, the director of the Prevention and Access to Care and Treatment project, which is based on "a model that Partners in Health pioneered to fight HIV in rural Haiti and drug-resistant tuberculosis in Peru."
Domestic and international air travel helped spread the novel coronavirus in Brazil, a study has found, as tourism bodies push for global travel to resume amid infection resurgences in some countries.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the initiation of a Phase 2 clinical trial with ACE-031 in patients with Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease. ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting signaling of a cell surface receptor called the activin receptor type IIB (ActRIIB).
By applying a systems biology approach, a recent bioRxiv* preprint research paper by scientists from the Icahn School of Medicine at Mount Sinai in New York unveils interactions between the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and p38 mitogen-activated protein kinase (MAPK) pathway responsible for regulating the expression of crucial inflammatory mediators in human lung epithelial cells.
› Verified 1 days ago
Mrs. Kathleen Forehand Hall, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket Street, Fairbanks, AK 99709 Phone: 907-452-4517 Fax: 907-452-4263 | |
Conversation Station Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 University Ave Ste 110, Fairbanks, AK 99709 Phone: 907-687-6309 | |
Ms. Heather E Eisenman, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1528 Bluegrass Dr, Fairbanks, AK 99709 Phone: 707-364-2013 | |
Kerry Rae Pippin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 1st Ave, Fairbanks, AK 99701 Phone: 907-347-6494 | |
David Jamison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket St, Fairbanks, AK 99709 Phone: 907-452-4517 | |
Mrs. Melinda Alexandria Mihalich, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1327 Kalakaket Street, Fairbanks, AK 99709 Phone: 907-452-4517 Fax: 907-452-4263 | |
Mackenzee Heath, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Chapman Ct, Fairbanks, AK 99709 Phone: 907-374-1686 Fax: 866-308-4995 |